Influence of glucagon-like peptide 2 on energy homeostasis

Peptides

Volumn 86, Issue , 2016, Pages 1-5

  Baldassano, Sara ^a   Amato, Antonella ^a   Mulè, Flavia ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Food intake; GLP 2; Insulin resistance; L type enteroendocrine cells; Obesity

Indexed keywords

CHYLOMICRON; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 2; GLUCAGON LIKE PEPTIDE 2 RECEPTOR; PROOPIOMELANOCORTIN; GLUCOSE;

ENERGY ABSORPTION; ENERGY BALANCE; FOOD INTAKE; GASTROINTESTINAL MOTILITY; GLUCONEOGENESIS; GLUCOSE METABOLISM; HORMONE RELEASE; HUMAN; INTESTINE ABSORPTION; INTESTINE MUCOSA; LIPID DIET; MESENTERY BLOOD FLOW; METABOLIC DISORDER; NONHUMAN; NUTRIENT UPTAKE; OBESITY; PRIORITY JOURNAL; REVIEW; STOMACH EMPTYING; ANIMAL; APPETITE; CALORIC INTAKE; ENERGY METABOLISM; GASTROINTESTINAL ABSORPTION; GASTROINTESTINAL TRACT; HOMEOSTASIS; METABOLISM; PHYSIOLOGY;

ANIMALS; APPETITE; ENERGY INTAKE; ENERGY METABOLISM; GASTROINTESTINAL ABSORPTION; GASTROINTESTINAL TRACT; GLUCAGON-LIKE PEPTIDE 2; GLUCOSE; HOMEOSTASIS; HUMANS;

EID: 84988484565     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2016.09.010     Document Type: Review

References (81)

1. [1] Ahrén, B., Glucagon secretion in relation to insulin sensitivity in healthy subjects. Diabetologia 49 (2006), 117–122.
2. [2] Akiba, Y., Kaunitz, J.D., Duodenal luminal chemosensing; acid, ATP, and nutrients. Curr. Pharm. Des. 20 (2014), 2760–2765.
3. [3] Amato, A., Baldassano, S., Mulè, F., GLP2: an underestimated signal for improving glycaemic control and insulin sensitivity. J. Endocrinol. 229 (2016), R57–66.
4. [4] Amato, A., Baldassano, S., Serio, R., Mulè, F., Glucagon-like peptide-2 relaxes mouse stomach through vasoactive intestinal peptide release. Am. J. Physiol. Gastrointest. Liver Physiol. 296 (2009), G678–G684.
5. [5] Amato, A., Rotondo, A., Cinci, L., Baldassano, S., Vannucchi, M.G., Mule, F., Role of cholinergic neurons in themotor effects of glucagon-like peptide-2 in mouse colon. Am. J. Physiol. Gastrointest. Liver Physiol. 299 (2010), G1038–44.
6. [6] Angelone, T., Filice, E., Quintieri, A.M., Imbrogno, S., Amodio, N., Pasqua, T., et al. Receptor identification and physiological characterization of glucagon-like peptide-2 in the rat heart. Nutr. Metab. Cardiovasc. Dis. 22 (2012), 486–494.
7. [7] Au, A., Gupta, A., Schembri, P., Cheeseman, C.I., Rapid insertion of GLUT2 into the rat jejunal brush-border membrane promoted by glucagon-like peptide 2. Biochem. J 367 (2002), 247–254.
8. [8] Baggio, L.L., Drucker, D.J., Biology of incretins: GLP-1 and GIP. Gastroenterology 132 (2007), 2131–2157.
9. [9] Bahrami, J., Longuet, C., Baggio, L.L., Li, K., Drucker, D.J., The glucagon-like peptide-2 receptor modulates islet adaptation to metabolic stress in the ob/ob mouse. Gastroenterology 139 (2010), 857–868.
10. [10] Baldassano, S., Amato, A., GLP-2: what do we know? What are we going to discover?. Regul. Pept.(194–195), 2014, 6–10.
11. [11] Baldassano, S., Amato, A., Caldara, G.F., Mulè, F., Glucagon-like peptide-2 treatment improves glucose dysmetabolism in mice fed a high fat diet. Endocrine, 2016, 10.1007/s12020-016-0871-3 in press.
12. [12] Baldassano, S., Amato, A., Cappello, F., Rappa, F., Mulè, F., Glucagon-like peptide-2 and mouse intestinal adaptation to a high-fat diet. J. Endocrinol. 217 (2013), 11–20.
13. [13] Baldassano, S., Amato, A., Rappa, F., Cappello, F., Mulè, F., Influence of endogenous glucagon like peptide-2 on lipid disorders in mice fed a high fat diet. Endocr. Res. 23 (2016), 1–8.
14. [14] Baldassano, S., Bellanca, A.L., Serio, R., Mulè, F., Food intake in lean and obese mice after peripheral administration of glucagon-like peptide 2. J. Endocrinol. 213 (2012), 277–284.
15. [15] Baldassano, S., Liu, S., Qu, M.H., Mulè, F., Wood, J.D., Glucagon-like peptide-2 modulates neurally evoked mucosal chloride secretion in guinea pig small intestine in vitro. Am. J. Physiol. Gastrointest. Liver Physiol. 297 (2009), G800–G805.
16. [16] Baldassano, S., Rappa, F., Amato, A., Cappello, F., Mulè, F., GLP-2 as beneficial factor in the glucose homeostasis in mice fed a high fat diet. J. Cell. Physiol. 230 (2015), 3029–3036.
17. [17] Bremholm, L., Hornum, M., Andersen, U.B., Hartmann, B., Holst, J.J., Jeppesen, P.B., The effect of glucagon-like peptide-2 on mesenteric blood low and cardiac parameters in end-jejunostomy short bowel patients. Regul. Pept. 168 (2011), 32–38.
18. [18] Brubaker, P.L., The glucagon-like peptides: pleiotropic regulators of nutrient homeostasis. Ann. N. Y. Acad. Sci. 1070 (2006), 10–26.
19. [19] Brubaker, P.L., Crivici, A., Izzo, A., Ehrlich, P., Tsai, C.H., Drucker, D.J., Circulating and tissue forms of the intestinal growth factor, glucagon-likepeptide-2. Endocrinology 138 (1997), 4837–4843.
20. [20] Burrin, D., Stoll, B., Jiang, R., Petersen, Y., Elnif, J., Buddington, R.K., et al. GLP-2 stimulates intestinal growth in premature TPN-fed pigs by suppressing proteolysis and apoptosis. Am. J. Physiol. Gastrointest. Liver Physiol. 279 (2000), 1249–1256.
21. [21] Caddy, G.R., Ardill, J.E., Fillmore, D., Caldwell, C.M., McKibben, B.M., Gardiner, K.R., et al. Plasma concentrations of glucagon-like peptide-2 in adult patients with treated and untreated coeliac disease. Eur. J. Gastroenterol. Hepatol. 18 (2006), 195–202.
22. [22] Cani, P.D., Possemiers, S., Van de Wiele, T., Guiot, Y., Everard, A., Rottier, O., et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58 (2009), 1091–1103.
23. [23] Chance, W.T., Foley-Nelson, T., Thomas, I., Balasubramaniam, A., Prevention of parenteral nutrition-induced gut hypoplasia by coinfusion of glucagonlikepeptide-2. Am. J. Physiol. 273 (1997), G559–G663.
24. [24] Cheeseman, C.I., Upregulation of SGLT-1 transport activity in rat jejunum induced by GLP-2 infusion in vivo. Am. J. Physiol. Regul. Integr. Comp. Physiol. 273 (1997), R1965–R1971.
25. [25] Cinci, L., Faussone-Pellegrini, M.S., Rotondo, A., Mulè, F., Vannucchi, M.G., GLP-2 receptor expression in excitatory and inhibitory enteric neurons and its role in mouse duodenum contractility. Neurogastroenterol. Motil. 23 (2011), e383–e392.
26. [26] Connor, E.E., Evock-Clover, C.M., Walker, M.P., Elsasser, T.H., Kahl, S., Comparative gut physiology symposium: comparative physiology of glucagon-like peptide-2: Implications and applications for production and health of ruminants. J. Anim. Sci. 93 (2015), 492–501.
27. [27] Cottrell, J.J., Stoll, B., Buddington, R.K., Stephens, J.E., Cui, L., Chang, X., et al. Glucagon-like peptide-2 protects against TPN-induced intestinal hexose malabsorption in enterally refed piglets. Am. J. Physiol. Gastrointest. Liver Physiol. 290 (2006), G293–G300.
28. [28] Daly, K., Al-Rammahi, M., Arora, D.K., Moran, A.W., Proudman, C.J., Ninomiya, Y., et al. Expression of sweet receptor components in equine small intestine: relevance to intestinal glucose transport. Am. J. Physiol. Regul. Integr. Comp. Physiol. 303 (2012), R199–R208.
29. [29] Dash, S., Xiao, C., Morgantini, C., Connelly, P.W., Patterson, W.B., Lewis, G.F., Glucagon-like peptide 2 regulates release of chylomicron from the intestine. Gastroenterology 2 (2014), 1–10.
30. [30] Deane, A.M., Nguyen, N.Q., Stevens, J.E., Fraser, R.J.L., Holloway, R.H., Besanko, L.K., et al. Endogenous glucagon-like peptide-1 slows gastric emptying in healthy subjects, attenuating postprandial glycemia. J. Clin. Endocrinol. Metabol. 95 (2010), 215–221.
31. [31] Drucker, D.J., Erlich, P., Asa, S.L., Brubaker, P.L., Induction of intestinal epithelial proliferation by glucagonlike peptide 2. Proc. Natl. Acad. Sci. U. S. A. 93 (1996), 7911–7916.
32. [32] Drucker, D.J., Nauck, M.A., The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 368 (2006), 1696–1705.
33. [33] Drucker, D.J., Yusta, B., Physiology and pharmacology of the enteroendocrine hormone glucagon-like peptide-2. Ann. Rev. Physiol. 76 (2014), 561–583.
34. [34] El-Jamal, N., Erdual, E., Neunlist, M., Koriche, D., Dubuquoy, C., Maggiotto, F., et al. Glugacon-like peptide-2: broad receptor expression, limited therapeutic effect on intestinal inflammation and novel role in liver regeneration. Am. J. Physiol. Gastrointest. Liver Physiol. 307 (2014), G274–G285.
35. [35] McGirr, R., Guizzetti, L., Dhanvantari, S., The sorting of proglucagon to secretory granules is mediated by carboxypeptidase E and intrinsic sorting signals. J. Endocrinol. 217 (2013), 229–240.
36. [36] Guan, X., The CNS glucagon-like peptide-2 receptor in the control of energy balance and glucose homeostasis. Am. J. Physiol. Reg. Int. Comp. Physiol. 307 (2014), R585–R596.
37. [37] Guan, X., Karpen, H.E., Stephens, J., Bukowski, J.T., Niu, S., Zhang, G., et al. GLP-2 receptor localised to enteric neurons and endocrine cells expressing vasoactive peptides and mediates increased blood flow. Gastroenterology 130 (2006), 150–164.
38. [38] Guan, X., Shi, X., Li, X., Chang, B., Wang, Y., Li, D.P., et al. GLP-2 receptor in POMC neurons suppresses feeding behavior and gastric motility. Am. J. Physiol. Endocrinol. Metab. 303 (2012), E853–E864.
39. [39] Guizzetti, L., McGirr, R., Dhanvantari, S., Two dipolar α-helices within hormone-encoding regions of proglucagon are sorting signals to the regulated secretory pathway. J. Biol. Chem. 289 (2014), 14968–14980.
40. [40] Hartmann, B., Harr, M.B., Jeppesen, P.B., Wojdemann, M., Deacon, C.F., Mortensen, P.B., et al. In vivo and in vitro degradation of glucagon like peptide-2 in humans. J. Clin. Endocrinol. Metab. 85 (2000), 2884–2888.
41. [41] Hein, G.J., Baker, C., Hsieh, J., Farr, S., Adeli, K., GLP-1 and GLP-2 as yin and yang of intestinal lipoprotein production: evidence for predominance of GLP-2-stimulated postprandial lipemia in normal and insulin-resistant states. Diabetes 62 (2013), 373–381.
42. [42] Honda, K., Glucagon-related peptides and the regulation of food intake in chickens. Anim. Sci. J., 2016, 10.1111/asj.12619 (Epub ahead of print).
43. [43] Honda, K., Saneyasu, T., Shimatani, T., Aoki, K., Yamaguchi, T., Nakanishi, K., et al. Intracerebroventricular administration of chicken glucagon-like peptide-2 potently suppresses food intake in chicks. Anim. Sci. J. 86 (2015), 312–318.
44. [44] Honda, K., Shimatani, T., Aoki, K., Yamaguchi, T., Kondo, M., Saneyasu, T., et al. Glucagon-like peptide-2 functions as anorexigenic peptide not only in the central nervous system but also in the peripheral circulation in broiler chicks. Poult. Sci. 3 (2015), 183–187.
45. [45] Hsieh, J., Longuet, C., Maida, A., Bahrami, J., Xu, E., Baker, C.L., et al. Glucagon-like peptide-2 increases intestinal lipid absorption and chylomicron production via CD36. Gastroenterology 137 (2009), 997–1005.
46. [46] Hu, X.F., Guo, Y.M., Huang, B.Y., Bun, S., Zhang, L.B., Li, J.H., et al. The effect of glucagon-like peptide 2 injection on performance, small intestinal morphology, and nutrient transporter expression of stressed broiler chickens. Poult. Sci. 89 (2010), 1967–1974.
47. [47] Janssen, P., Rotondo, A., Mulè, F., Tack, J., Review article: a comparison of glucagon-like peptides 1 and 2. Aliment. Pharmacol. Ther. 37 (2013), 18–36.
48. [48] Jeppesen, P.B., Hartmann, B., Thulesen, J., Hansen, B.S., Holst, J.J., Poulsen, S.S., et al. Elevated plasma glucagon-like peptide 1 and 2 concentrations in ileum resected short bowel patients with a preserved colon. Gut 47 (2000), 370–376.
49. [49] Jeppesen, P.B., Sanguinetti, E.L., Buchman, A., Howard, L., Scolapio, J.S., Ziegler, T.R., et al. Teduglutide (ALX-0600), a dipeptidylpeptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients. Gut 54 (2005), 1224–1231.
50. [50] Kissow, H., Glucagon-like peptides 1 and 2: intestinal hormones implicated in the pathophysiology of mucositis. Curr. Opin. Support. Palliat. Care 9 (2015), 196–202.
51. [51] Lee, S.K., Opara, E.C., Surwit, R.S., Feinglos, M.N., Akwari, O.E., Defective glucose-stimulated insulin release from perifused islets of C57BL/6J mice. Pancreas 11 (1995), 206–211.
52. [52] Lovshin, J., Estall, J., Yusta, B., Brown, T.J., Drucker, D.J., Glucagon-like peptide (GLP)-2 action in the murine central nervous system is enhanced by elimination of GLP-1 receptor signaling. J. Biol. Chem. 276 (2001), 21489–21499.
53. [53] Lovshin, J.A., Huang, Q., Seaberg, R., Brubaker, P.L., Drucker, D.J., Extrahypothalamic expression of the glucagon-like peptide-2 receptor is coupled to reduction of glutamate-induced cell death in cultured hippocampal cells. Endocrinology 145 (2004), 3495–3506.
54. [54] Meier, J.J., Nauck, M.A., Pott, A., Heinze, K., Goetze, O., Bulut, K., et al. Glucagon-like peptide 2 stimulates glucagon secretion, enhances lipid absorption, and inhibits gastric acid secretion in humans. Gastroenterology 130 (2006), 44–54.
55. [55] Nagell, C.F., Wettergren, A., Pedersen, J.F., Mortensen, D., Holst, J.J., Glucagon-like peptide-2 inhibits antral emptying in man, but is not as potent as glucagon-like peptide-1. Scand. J. Gastroenterol. 39 (2004), 353–358.
56. [56] Nishimura, K., Hiramatsu, K., Monir, M.M., Takemoto, C., Watanabe, T., Ultrastructural study on colocalization of glucagon-like peptide (GLP)-1 with GLP-2 in chicken intestinal L-cells. J. Vet. Med. Sci. 75 (2013), 1335–1339.
57. [57] Nuzzo, D., Picone, P., Baldassano, S., Caruana, L., Messina, E., Marino Gammazza, A., et al. Insulin resistance as common molecular denominator linking obesity to Alzheimer's disease. Curr. Alzheimer Res. 12 (2015), 723–735.
58. [58] Ørskov, C., Holst, J.J., Nielsen, O.V., Effect of truncated glucagon-like peptide-1 [proglucagon-(78–107) amide] on endocrine secretion from pig pancreas, antrum, and nonantral stomach. Endocrinology 123 (1988), 2009–2013.
59. [59] Petersen, Y.M., Burrin, D.G., Sangild, P.T., GLP-2 has differential effects on small intestine growth and function in fetal and neonatal pigs. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281 (2001), R1986–R1993.
60. [60] Petersen, Y.M., Elnif, J., Schmidt, M., Sangild, P.T., Glucagon-like peptide 2 enhances maltase-glucoamylase and sucrase-isomaltase gene expression and activity in parenterally fed premature neonatal piglets. Pediatr. Res. 52 (2002), 498–503.
61. [61] Ramsanahie, A., Duxbury, M.S., Grikscheit, T.C., Perez, A., Rhoads, D.B., Gardner-Thorpe, J., et al. Effect of GLP-2 on mucosal morphology and SGLT1 expression in tissue-engineered neointestine. Am. J. Physiol. Gastrointest. Liver Physiol. 285 (2003), G1345–G1352.
62. [62] Rotondo, A., Amato, A., Baldassano, S., Lentini, L., Mulè, F., Gastric relaxation induced by glucagon-like peptide-2 in mice fed a high-fat diet or fasted. Peptides 32 (2011), 1587–1592.
63. [63] Rotondo, A., Amato, A., Lentini, L., Baldassano, S., Mulè, F., Glucagon-like peptide-1 relaxes gastric antrum through nitric oxide in mice. Peptides 32 (2011), 60–64.
64. [64] Sangild, P.T., Tappenden, K.A., Malo, C., Petersen, Y.M., Elnif, J., Bartholome, A.L., et al. Glucagon-like peptide 2 stimulates intestinal nutrient absorption in parenterally fed newborn pigs. J. Pediatr. Gastroenterol. Nutr. 43 (2006), 160–167.
65. + T cells. Scand. J. Gastroenterol. 35 (2000), 522–527.
66. [66] Schmidt, P.T., Näslund, E., Grybäck, P., Jacobsson, H., Hartmann, B., Holst, J.J., et al. Peripheral administration of GLP-2 to humans has no effect on gastric emptying or satiety. Regul. Pept. 116 (2003), 21–25.
67. [67] Schmidt, W.E., Siegel, E.G., Creutzfeldt, W., Glucagon-like peptide-1 but not glucagon-like peptide-2 stimulates insulin release from isolated rat pancreatic islets. Diabetologia 28 (1985), 704–707.
68. [68] Shi, X., Zhou, F., Li, X., Chang, B., Li, D., Wang, Y., et al. Central GLP-2 enhances hepatic insulin sensitivity via activating PI3 K signaling in POMC neurons. Cell Metab. 18 (2013), 86–98.
69. [69] Shin, E.D., Estall, J.L., Izzo, A., Drucker, D.J., Brubaker, P.L., Mucosal adaptation to enteral nutrients is dependent on the physiologic actions of glucagon-like peptide-2 in mice. Gastroenterology 128 (2005), 1340–1353.
70. [70] Sörensen, L.B., Flint, A., Raben, A., Hartmann, B., Holst, J.J., Astrup, A., No effect of physiological concentrations of glucagonlike peptide-2 on appetite and energy intake in normal weight subjects. Int. J. Obes. Relat. Metab. Disord. 27 (2003), 450–456.
71. [71] Surwit, R.S., Kuhn, C.M., Cochrane, C., McCubbin, J.A., Feinglos, M.N., Diet-induced type II diabetes in C57BL/6J mice. Diabetes 37 (1988), 1163–1167.
72. [72] Tang-Christensen, M., Larsen, P.J., Thulesen, J., Rømer, J., Vrang, N., The proglucagon-derived peptide, glucagon-like peptide-2, is a neurotransmitter involved in the regulation of food intake. Nat. Med. 6 (2000), 802–807.
73. [73] Tsai, C.H., Hill, M., Asa, S.L., Brubaker, P.L., Drucker, D.J., Intestinal growth promoting properties of glucagon-like peptide-2 in mice. Am. J. Physiol. Endocrinol. Metab. 273 (1997), E77–E84.
74. [74] Tsai, C.H., Hill, M., Drucker, D.J., Biological determinants of intestinotrophic properties of GLP-2 in vivo. Am. J. Physiol. 272 (1997), G662–G668.
75. [75] Varndell, I.M., Bishop, A.E., Sikri, K.L., Uttenthal, L.O., Bloom, S.R., Polak, J.M., Localization of glucagon-like peptide (GLP) immunoreactants in human gut and pancreas using light and electron microscopic immunocytochemistry. J. Histochem. Cytochem. 33 (1985), 1080–1086.
76. [76] Vrang, N., Larsen, P.J., Preproglucagon derived peptides GLP-1, GLP-2 and oxyntomodulin in the CNS: role of peripherally secreted and centrally produced peptides. Prog. Neurobiol. 92 (2010), 442–462.
77. [77] Wallis, K., Walters, J.R., Forbes, A., Review article: glucagon-like peptide 2–current applications and future directions. Aliment. Pharmacol. Ther. 25 (2007), 365–372.
78. [78] Wang, J.H., Inoue, T., Higashiyama, M., Guth, P.H., Engel, E., Kaunitz, J.D., et al. Umami receptor activation increases duodenal bicarbonate secretion via glucagon-like peptide-2 release in rats. J. Pharmacol. Exp. Ther. 339 (2011), 464–473.
79. [79] Wøjdemann, M., Wettergren, A., Hartmann, B., Hilsted, L., Holst, J.J., Inhibition of sham feeding-stimulated human gastric acid secretion by glucagon-like peptide-2. J. Clin. Endocrinol. Metab. 84 (1999), 2513–2517.
80. [80] Yusta, B., Huang, L., Munroe, D., Wolff, G., Fantaske, R., Sharma, S., et al. Enteroendocrine localization of GLP-2 receptor expression in humans and rodents. Gastroenterology 119 (2000), 744–755.
81. [81] Zhu, X., Zhou, A., Dey, A., Norrbom, C., Carroll, R., Zhang, C., Laurent, V., Lindberg, I., Ugleholdt, R., Holst, J.J., Steiner, D.F., Disruption of PC1/3 expression in mice causes dwarfism and multiple neuroendocrine peptide processing defects. Proc. Natl. Acad. Sci. U. S. A. 99 (2002), 10293–10298.